X

Stay Connected

Sign Up for Updates

network1.png

PPA strives to improve patient health, advance medical innovation and fuel economic growth.

LEARN MORE
network1.png

The PhRMA Foundation supports the research and career endeavors of scientists in drug discovery and development.

LEARN MORE
network1.png

Access Better Coverage educates consumers about the ABCs of health coverage and access to medicines.

LEARN MORE
network1.png

We Work For Health aims to increase awareness by uniting workers throughout the industry.

LEARN MORE
network1.png

Patent protection should always be considered by an inventor during the initial stages of their invention.

LEARN MORE
logo_white_MyOldMeds-New-1.png

Working to spread awareness and education about the importance of secure drug disposal.

LEARN MORE
LTAC_NEW21.png

Many Americans are struggling to afford their medicines and have important questions about their medicine costs. Let's Talk About Cost addresses these questions.

LEARN MORE
logo_white_LTAM.png

There are a lot of conversations in Washington about how to change Medicare Part D, but they aren't always focused on what seniors care about most: affordability and predictability.

LEARN MORE
 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.
Jackie McRae

Jackie McRae is a Director of Policy, Research, and Membership at PhRMA focusing on health equity and the value of medicines. Jackie graduated with a Doctorate of Pharmacy from Mercer University and Master of Science in Applied Health Economics and Outcomes Research from Thomas Jefferson University. Jackie previously worked as a Post-Doctoral Fellow in Health Economics and Outcomes Research at Janssen Scientific Affairs and Thomas Jefferson University. Outside the office, Jackie can be found hiking on local trails and enjoying scenic drives.

Recent Posts

You won’t fix what you don’t value: Two reasons why traditional cost-effective analyses can perpetuate health inequities

By Jackie McRae  |    June 16, 2022
A new report from Partnership for Health Analytic Research or PHAR describes how value assessments that use traditional cost-effectiveness analyses can overlook important health disparities and risk...   Read More

PhRMA presents research at ISPOR 2022

By Jackie McRae  |    May 26, 2022
Last week at the ISPOR annual international meeting, PhRMA partnered with multiple organizations committed to advancing value assessment research and methods. We worked with a range of academics,...   Read More

Addressing social determinants of health to improve equitable access to medicines

By Jackie McRae  |    May 19, 2022
PhRMA Awards $150,000 to Address Social Determinants of Health:Announcing the Recipients of Round 4 of the PhRMA Collaborative Actions to Reach Equity (CAREs) Grant Program As part of PhRMA’s...   Read More

Announcing CAREs Grant Round 4

By Jackie McRae  |    November 12, 2021
Medicines can be critical to treating, managing, and sometimes curing illnesses, thereby offering an effective tool to improve health outcomes and reduce health disparities. However, numerous studies...   Read More

PhRMA awards $150,000 to community-based projects aimed at tackling inequities in access to COVID-19 testing, vaccines and therapeutics

By Jackie McRae  |    September 21, 2021
The COVID-19 pandemic has widened health disparities, including the gap in average life expectancy and outcomes for many chronic diseases. These inequities in health status and outcomes among racial...   Read More

New research shows hotspots of inequity relate to increased COVID-19 hospitalizations

By Jackie McRae  |    January 8, 2021
As part of PhRMA’s continuing work to address health inequities, we are partnering with researchers to study hotspots of COVID-19 and chronic disease inequities in New York state. Reports this summer...   Read More

PhRMA CAREs Grant request for proposals: Addressing racial disparities in medication utilization and adherence

By Jackie McRae  |    November 24, 2020
Systemic racism is as real as any disease, and our industry is not immune. This summer, in the wake of a national outcry for racial and social justice, our industry offered a firm stance – systemic...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates

Trending Posts

Most Popular Posts

Pharmaceutical Research and Manufacturers of America®
950 F Street, NW Suite 300, Washington, DC 20004

Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how
we and third parties use pixel tags, and how that use affects you, visit our privacy policy and review
"1. Information Collection."